Advanced Characterization Approaches for Quality Control of LNP Formulation

Time: 12:00 pm
day: Day Two


  • What considerations should be taken into account when formulating LNPs for various types of therapeutic payloads, such as mRNA, siRNA, or small molecules?
  • Addressing concerns related to immune response, biodistribution, and targeted delivery 
  • What strategies can be employed to improve the encapsulation of mRNA molecules within LNPs?